Clinical trial
Interferon Alfa in Treating Children With HIV-Related Cancer
NCT00002621 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002621 |
|---|---|
| Title | Interferon Alfa in Treating Children With HIV-Related Cancer |
| Official title | A Phase II Study of Alpha Interferon (alphaIFN) In HIV-Related Malignancies - A Pediatric Oncology Group Wide Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | recombinant interferon alfa |
| Enrollment | 8 |
| Start date | Dec 1, 1994 |
| Primary completion | Jul 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Aug 11, 2003 |
| Last update posted | Jul 24, 2014 |
| Countries | Canada, Puerto Rico, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: